Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
- 30 September 2007
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 194 (1), 175-181
- https://doi.org/10.1016/j.atherosclerosis.2006.07.024
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseasesJournal of Hepatology, 2006
- Plasma homocysteine thiolactone adducts associated with risk of coronary heart diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 2006
- The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease statusJournal of Lipid Research, 2005
- Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic miceAtherosclerosis, 2005
- Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiesJournal of Lipid Research, 2005
- Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout miceFree Radical Biology & Medicine, 2003
- Redox Imbalance and Its Control in HIV InfectionAntioxidants and Redox Signaling, 2002
- Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral TherapyClinical Immunology, 2001
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.JCI Insight, 1998
- Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1995